Form 4: VolitionRx Secretary Settles Restricted Stock Unit Tax Obligations Through Share Withholding

Sentiment:

Insider Transaction Report


VolitionRx Ltd.'s Secretary, Rodney Gerard Rootsaert, settled tax withholding obligations for restricted stock units by having 3,066 shares of common stock retained by the company.

Summary

  • Rodney Gerard Rootsaert, Secretary and Director of VolitionRx Ltd. (VNRX), had 3,066 shares of common stock retained by the company on July 1, 2025.
  • The shares, valued at $0.7679 each, were withheld to satisfy tax obligations arising from the settlement of 7,302 restricted stock units (RSUs) awarded to Mr. Rootsaert in lieu of cash compensation.
  • No shares were sold by Mr. Rootsaert or VolitionRx in this transaction.
  • Following the transaction, Mr. Rootsaert beneficially owns 138,289 shares directly and 1,007,718 shares indirectly through Concord International, Inc., where he is a controlling director with shared voting and dispositive control.

Sentiment

Score: 5

Explanation: The transaction is a routine administrative event related to executive compensation and tax withholding, with no direct positive or negative implications for the company's financial health or operational outlook. The explicit statement that no shares were sold by the reporting person or the company is a neutral-to-slightly positive nuance.

Positives

  • The transaction represents the settlement of previously awarded restricted stock units, indicating the vesting and realization of compensation for the reporting person.
  • The filing explicitly states that no shares were sold by the reporting person or VolitionRx, indicating that the transaction was solely for tax withholding purposes rather than a divestment.

Negatives

  • The transaction itself, being a tax withholding event, does not inherently present negative implications for the company's operational or financial performance.

Future Outlook

The document does not provide any forward-looking statements or guidance regarding the company's future performance or strategic direction.

Industry Context

This Form 4 filing details a routine insider transaction related to executive compensation and tax obligations, which is common across all publicly traded companies. It does not provide information relevant to broader industry trends or competitive positioning.

Related Party Transactions

  • The transaction involves Rodney Gerard Rootsaert, an officer and director of VolitionRx Ltd., settling tax obligations for restricted stock units awarded by the company. This constitutes a transaction between a related party (executive) and the issuer.

Stakeholder Impact

  • Shareholders: Minimal direct impact. The transaction is a routine administrative event related to executive compensation and does not reflect a change in company strategy or financial performance. The shares withheld for tax are a small fraction of total outstanding shares.
  • Employees: No direct impact on general employees.

Key Dates

DateDescription
07/01/2025Date of transaction where 3,066 shares were disposed of for tax withholding.
07/03/2025Date the Form 4 was signed by Rodney Gerard Rootsaert.

Keywords

VolitionRx, VNRX, SEC Form 4, Insider Transaction, Restricted Stock Units, Tax Withholding, Beneficial Ownership, Corporate Secretary, Director

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.